Four weeks is the minimum because it takes approximately that long for semaglutide to reach a new steady state after any dosing change
It mimics the incretin hormone glucagonlike peptide1 (GLP1), leading to improved glycemic control, reduced appetite, delayed gastric emptying, and favorable effects on cardiovascular risk
It provides an alternative option for researchers who prefer nasal administration over injections or capsules
At $800-1,200 per month without insurance coverage, a six-month course of pharmaceutical GLP-1 treatment costs $4,800-7,200
Again, these aren't new, but the conversation around it is so new being in the general public is often women's periods, reproductive health